Virologic and Immunologic Events in Primary HIV Infection

Overview

Journal Springer Semin Immunopathol

Specialty Allergy & Immunology

Date 1997 Jan 1

PMID 9089948

Citations 8

Authors

G Pantaleo

C Graziosi

A S Fauci

Affiliations

Soon will be listed here.

Citing Articles

Altered distribution of mucosal NK cells during HIV infection.

Sips M, Sciaranghella G, Diefenbach T, Dugast A, Berger C, Liu Q Mucosal Immunol. 2011; 5(1):30-40.

PMID: 21993602 PMC: 3740353. DOI: 10.1038/mi.2011.40.

Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV.

Kelschenbach J, Saini M, Hadas E, Gu C, Chao W, Bentsman G J Neuroimmune Pharmacol. 2011; 7(2):380-7.

PMID: 21987348 PMC: 3487595. DOI: 10.1007/s11481-011-9316-1.

HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo.

Biancotto A, Iglehart S, Vanpouille C, Condack C, Lisco A, Ruecker E Blood. 2007; 111(2):699-704.

PMID: 17909079 PMC: 2200839. DOI: 10.1182/blood-2007-05-088435.

Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy.

Weekes M, Wills M, Sissons J, Carmichael A Immunology. 2006; 118(1):25-38.

PMID: 16630020 PMC: 1782266. DOI: 10.1111/j.1365-2567.2006.02334.x.

Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.

Zhang H, Fayad R, Wang X, Quinn D, Qiao L J Virol. 2004; 78(19):10249-57.

PMID: 15367590 PMC: 516374. DOI: 10.1128/JVI.78.19.10249-10257.2004.

References

Reimann K, Tenner-Racz K, Racz P, Montefiori D, Yasutomi Y, Lin W . Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol. 1994; 68(4):2362-70. PMC: 236713. DOI: 10.1128/JVI.68.4.2362-2370.1994. View

Pantaleo G, Graziosi C, Butini L, Pizzo P, Schnittman S, Kotler D . Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci U S A. 1991; 88(21):9838-42. PMC: 52816. DOI: 10.1073/pnas.88.21.9838. View

Meier U, Klenerman P, Griffin P, James W, Koppe B, Larder B . Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science. 1995; 270(5240):1360-2. DOI: 10.1126/science.270.5240.1360. View

Clark S, Saag M, DECKER W, Roberson J, Veldkamp P, Kappes J . High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991; 324(14):954-60. DOI: 10.1056/NEJM199104043241404. View

Denis M, Ghadirian E . Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens. Clin Exp Immunol. 1994; 97(1):76-82. PMC: 1534796. DOI: 10.1111/j.1365-2249.1994.tb06582.x. View

Schellekens P, Tersmette M, Roos M, Keet R, de Wolf F, Coutinho R . Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype. AIDS. 1992; 6(7):665-9. DOI: 10.1097/00002030-199207000-00008. View

Pantaleo G, Fauci A . Immunopathogenesis of HIV infection. Annu Rev Microbiol. 1996; 50:825-54. DOI: 10.1146/annurev.micro.50.1.825. View

Pantaleo G, Graziosi C, Fauci A . The role of lymphoid organs in the immunopathogenesis of HIV infection. AIDS. 1993; 7 Suppl 1:S19-23. View

Koup R, Safrit J, Cao Y, Andrews C, McLeod G, Borkowsky W . Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994; 68(7):4650-5. PMC: 236393. DOI: 10.1128/JVI.68.7.4650-4655.1994. View

10.

Pantaleo G, Demarest J, Schacker T, Vaccarezza M, Cohen O, Daucher M . The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A. 1997; 94(1):254-8. PMC: 19306. DOI: 10.1073/pnas.94.1.254. View

11.

Mackewicz C, Ortega H, Levy J . CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest. 1991; 87(4):1462-6. PMC: 295198. DOI: 10.1172/JCI115153. View

12.

Tindall B, Cooper D . Primary HIV infection: host responses and intervention strategies. AIDS. 1991; 5(1):1-14. View

13.

Pantaleo G, Graziosi C, Demarest J, Butini L, Montroni M, Fox C . HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 1993; 362(6418):355-8. DOI: 10.1038/362355a0. View

14.

Asjo B, Sharma U, Magnusson A, Barkhem T, Albert J, Olausson E . Naturally occurring HIV-1 isolates with differences in replicative capacity are distinguished by in situ hybridization of infected cells. AIDS Res Hum Retroviruses. 1990; 6(10):1177-82. DOI: 10.1089/aid.1990.6.1177. View

15.

Alkhatib G, Combadiere C, Broder C, Feng Y, Kennedy P, Murphy P . CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996; 272(5270):1955-8. DOI: 10.1126/science.272.5270.1955. View

16.

Tersmette M, Gruters R, de Wolf F, de Goede R, Lange J, Schellekens P . Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol. 1989; 63(5):2118-25. PMC: 250628. DOI: 10.1128/JVI.63.5.2118-2125.1989. View

17.

Borrow P, Lewicki H, Hahn B, Shaw G, Oldstone M . Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994; 68(9):6103-10. PMC: 237022. DOI: 10.1128/JVI.68.9.6103-6110.1994. View

18.

Cocchi F, Devico A, Garzino-Demo A, Arya S, Gallo R, Lusso P . Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995; 270(5243):1811-5. DOI: 10.1126/science.270.5243.1811. View

19.

Doranz B, Rucker J, Yi Y, Smyth R, Samson M, Peiper S . A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 1996; 85(7):1149-58. DOI: 10.1016/s0092-8674(00)81314-8. View

20.

Embretson J, Zupancic M, Ribas J, Burke A, Racz P, Tenner-Racz K . Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 1993; 362(6418):359-62. DOI: 10.1038/362359a0. View